New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines<sup>*</sup>

Phillip Read, Annemiek de Ruiter(ViiV Healthcare (Spain)), Simon I Hay(University of Washington), Sinead Costelloe(Guy's and St Thomas' NHS Foundation Trust), N Larbalestier(Guy's Hospital), Siobhan O’Shea(St Thomas' Hospital), Jan Welch(King's College - North Carolina), Fiona Lyons(St. James's Hospital), GP Taylor(St Mary's Hospital), Jane Mullen(St Thomas' Hospital)
HIV Medicine
August 1, 2008
10.1111/j.1468-1293.2008.00594.x
Cited by 20

Related Papers

The global distribution and burden of dengue
|Nature|2013|10.1k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.4k
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|6.7k
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k